Novo Nordisk A/S Common Stock (NY:NVO)Price and VolumeDetailed Quote
Top NewsMore News
Performance
52-Week Range
41.2% below 52-week high
37.74
35.1252W Low
64.1652W High
1 Week
2.7% below 1-week high
36.841W Low
38.771W High
Novo Nordisk A/S Common Stock (NVO) traded between $35.12 and $64.16 over the past 52 weeks and last traded at $37.74, 41.2% below its 52-week high. Over the past week it ranged between $36.84 and $38.77.
Past 12 Months
-0.4%
-16.4%
-24.0%
+2.2%
-28.0%
-36.7%
1W
-$0.17
1M
-$7.42
3M
-$11.90
6M
+$0.83
YTD
-$14.65
1Y
-$21.91
NVO was -36.7% over the past year, +2.2% over six months, -28.0% year to date, -0.4% in the last week.
12 Months vs Market
NVO
DIA
SPY
QQQ
IWM
Over the past 12 months NVO returned -36.7% versus DIA (Dow) +9.1%, SPY (S&P 500) +15.3%, QQQ (Nasdaq 100) +24.0% and IWM (Russell 2000) +12.5%.
Volume & Liquidity
0.19× 3-mo avg
Today 2,362,314
3-mo avg 12.5M
1W
1M
3M
6M
YTD
1Y
NVO most recently traded 2,362,314 shares against a 3-month average daily volume of 12.5M. More NewsRead More
Better High-Yield Dividend Stock: Pfizer or Novo Nordisk? ↗
October 04, 2026
Via The Motley Fool
Via The Motley Fool
Topics
Intellectual Property
Novo Is Open to Acquisitions. Here Are 2 Companies That Would Be Great Candidates to Buy ↗
September 30, 2026
Via The Motley Fool
Topics
Initial Public Offering
3 Emerging Biotech Stocks With Significant Upside Potential ↗
September 30, 2026
Via MarketBeat
Topics
Intellectual Property
4 Stocks That Could Split Next—and Why Investors Are Watching ↗
September 30, 2026
Via MarketBeat
Topics
Artificial Intelligence
Novo Nordisk Gives Uninspiring Outlook ↗
September 29, 2026
Via The Motley Fool
Opinion: Eli Lilly Stock Is a No-Brainer Pick to Buy on the Dip ↗
September 29, 2026
Via The Motley Fool
Eli Lilly Just Announced Game-Changing News ↗
September 28, 2026
Via The Motley Fool
Here's Where Wall Street Analysts See Eli Lilly's Share Price Going ↗
September 26, 2026
Via The Motley Fool
Via The Motley Fool
Topics
Intellectual Property
Could This Be Novo Nordisk’s Next Billion-Dollar Weight-Loss Product? ↗
September 25, 2026
Via The Motley Fool
AbbVie vs. Novo Nordisk: Which Drug Giant Stock Is a Better Buy in 2026? ↗
September 24, 2026
Via The Motley Fool
Topics
Intellectual Property
Viking's Obesity Edge May Be Staying Power, Not Weight Loss ↗
September 23, 2026
Via MarketBeat
Eli Lilly Keeps Pulling Ahead—Can Novo Nordisk Catch Up? ↗
September 23, 2026
Via MarketBeat
Why Viking Therapeutics Stock Skyrocketed on Tuesday ↗
September 23, 2026
Via The Motley Fool
Via The Motley Fool
Novo Nordisk Targets Five Multi-Blockbusters by 2030 as Oral Wegovy Gains Traction ↗
September 21, 2026
Via MarketBeat
Why Novo Nordisk Stock Just Crashed ↗
September 21, 2026
Via The Motley Fool
Frequently Asked QuestionsIs Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 37.74
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 10/07/26 10:16 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
>